These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 8786536)
1. Methcathinone: an initial study of its effects on monoaminergic systems. Gygi MP; Gibb JW; Hanson GR J Pharmacol Exp Ther; 1996 Mar; 276(3):1066-72. PubMed ID: 8786536 [TBL] [Abstract][Full Text] [Related]
2. Role of endogenous dopamine in the neurochemical deficits induced by methcathinone. Gygi MP; Fleckenstein AE; Gibb JW; Hanson GR J Pharmacol Exp Ther; 1997 Dec; 283(3):1350-5. PubMed ID: 9400010 [TBL] [Abstract][Full Text] [Related]
3. Methcathinone decreases dopamine transporter function: Role of protein kinase C. Magee CP; Le BD; Siripathane YH; Wilkins DG; Hanson GR; Fleckenstein AE J Neurochem; 2021 Oct; 159(1):116-127. PubMed ID: 34320222 [TBL] [Abstract][Full Text] [Related]
4. Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse. Sparago M; Wlos J; Yuan J; Hatzidimitriou G; Tolliver J; Dal Cason TA; Katz J; Ricaurte G J Pharmacol Exp Ther; 1996 Nov; 279(2):1043-52. PubMed ID: 8930215 [TBL] [Abstract][Full Text] [Related]
6. Methcathinone and 3-Fluoromethcathinone Stimulate Spontaneous Horizontal Locomotor Activity in Mice and Elevate Extracellular Dopamine and Serotonin Levels in the Mouse Striatum. Wojcieszak J; Andrzejczak D; Wojtas A; Gołembiowska K; Zawilska JB Neurotox Res; 2019 Apr; 35(3):594-605. PubMed ID: 30377956 [TBL] [Abstract][Full Text] [Related]
7. The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes. Blough BE; Decker AM; Landavazo A; Namjoshi OA; Partilla JS; Baumann MH; Rothman RB Psychopharmacology (Berl); 2019 Mar; 236(3):915-924. PubMed ID: 30341459 [TBL] [Abstract][Full Text] [Related]
8. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice. Lin Z; Dodd CA; Filipov NM Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127 [TBL] [Abstract][Full Text] [Related]
9. Response of monoaminergic and neuropeptide systems to 4-methylaminorex: a new stimulant of abuse. Hanson GR; Bunker CF; Johnson M; Bush L; Gibb JW Eur J Pharmacol; 1992 Aug; 218(2-3):287-93. PubMed ID: 1358636 [TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse. Young R; Glennon RA Psychopharmacology (Berl); 1998 Dec; 140(3):250-6. PubMed ID: 9877004 [TBL] [Abstract][Full Text] [Related]
11. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Broening HW; Morford LL; Vorhees CV Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503 [TBL] [Abstract][Full Text] [Related]
12. Neurochemical effects of amphetamine metabolites on central dopaminergic and serotonergic systems. Matsuda LA; Hanson GR; Gibb JW J Pharmacol Exp Ther; 1989 Dec; 251(3):901-8. PubMed ID: 2600821 [TBL] [Abstract][Full Text] [Related]
13. The herbicide glyphosate causes behavioral changes and alterations in dopaminergic markers in male Sprague-Dawley rat. Hernández-Plata I; Giordano M; Díaz-Muñoz M; Rodríguez VM Neurotoxicology; 2015 Jan; 46():79-91. PubMed ID: 25522657 [TBL] [Abstract][Full Text] [Related]
14. Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels. Themann C; Alvarez Fischer D; Gross S; Westermann R; Weihe E; Kuschinsky K; Schäfer H; Ferger B Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):22-8. PubMed ID: 11862330 [TBL] [Abstract][Full Text] [Related]
15. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats. Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615 [TBL] [Abstract][Full Text] [Related]
16. Exacerbation of methamphetamine-induced neurochemical deficits by melatonin. Gibb JW; Bush L; Hanson GR J Pharmacol Exp Ther; 1997 Nov; 283(2):630-5. PubMed ID: 9353379 [TBL] [Abstract][Full Text] [Related]
17. Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone. López-Arnau R; Martínez-Clemente J; Pubill D; Escubedo E; Camarasa J J Psychopharmacol; 2014 Nov; 28(11):1053-63. PubMed ID: 25237120 [TBL] [Abstract][Full Text] [Related]
18. Methcathione ("cat"): an enantiomeric potency comparison. Glennon RA; Young R; Martin BR; Dal Cason TA Pharmacol Biochem Behav; 1995 Apr; 50(4):601-6. PubMed ID: 7617707 [TBL] [Abstract][Full Text] [Related]
19. Effect of low doses of L-NAME on methamphetamine-induced dopaminergic depletion in the rat striatum. Abekawa T; Ohmori T; Honda M; Ito K; Koyama T J Neural Transm (Vienna); 2001; 108(11):1219-30. PubMed ID: 11768623 [TBL] [Abstract][Full Text] [Related]
20. Neurochemical basis for cocaine and methamphetamine interactions. Hanson G; Matsuda L; Gibb J NIDA Res Monogr; 1988; 81():94-100. PubMed ID: 2457162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]